Amit M Oza (Amit Oza)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature reviews. Clinical oncology

University Health Network

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Health Network May 01 1987

Canada

Head, DMOH :: Division of Medical Oncology and Hematology

Publications

Ana Carolina Veneziani, Suku Sneha, Amit M Oza
Antibody-Drug Conjugates: Advancing from magic bullet to biological missile. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana Carolina Veneziani, Suku Sneha, Amit M Oza
Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Ana C Veneziani, Eduardo Gonzalez-Ochoa, Husam Alqaisi, Ainhoa Madariaga, Gita Bhat, Marjan Rouzbahman, Suku Sneha, Amit M Oza
Heterogeneity and treatment landscape of ovarian carcinoma. Nature reviews. Clinical oncology (2023)
Rachel N Grisham, Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero, Peter Vuylsteke, Robert L Coleman, Felix Hilpert, Amit M Oza, Anneke M Westermann, Martin K Oehler, Sandro Pignata, Carol Aghajanian, Nicoletta Colombo, David Cibula, Kathleen M Moore, Josep M Del Campo, Regina Berger, Christian Marth, Jalid Sehouli, David M O'Malley, Cristina Churruca, Gunnar B Kristensen, Andrew R Clamp, John Farley, Gopakumar V Iyer, Isabelle L Ray-Coquard, Bradley J Monk
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Oliver Dorigo, Amit M Oza, Tanja Pejovic, Prafull Ghatage, Sharad A Ghamande, Diane Provencher, Lisa D MacDonald, Heather L Torrey, Valarmathy Kaliaperumal, Walead Ebrahimizadeh, Heather A Hirsch, Yogesh Bramhecha, Jeannine Villella, Stephan Fiset
Maveropepimut-S, a DPX-based immune-educating therapy, shows promising and durable clinical benefit in patients with recurrent ovarian cancer, a phase 2 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ana Carolina Veneziani, Eduardo Gonzalez-Ochoa, Amit M Oza
Emerging peptide therapeutics for the treatment of ovarian cancer. Expert opinion on emerging drugs (2023)
Erika Paige Hamilton, Judy S Wang, Amit M Oza, Manish R Patel, Susanna V Ulahannan, Todd M Bauer, Janet L Karlix, Jorge Zeron-Medina, Giulia Fabbri, Paola Marco-Casanova, Ganesh Moorthy, Maureen M Hattersley, Gillian M Littlewood, Patrick D Mitchell, Jamal Saeh, Gayle P Pouliot, Kathleen M Moore
First-in-Human Study of AZD5153, A Small Molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. Molecular cancer therapeutics (2023)
Pamela Denisse Soberanis-Piña, Amit M Oza
Methodical Manipulation of the TME in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vikas Garg, Amit M Oza
Assessment of Homologous Recombination Deficiency in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Linda R Duska, Dmitriy Zamarin, Erika Paige Hamilton, Amit M Oza, Gini F Fleming, Alexander I Spira, Oladapo O Yeku, Debra L Richardson, Jackie Walling, Kerry Inokuchi, Bernice Matusow, Gideon Bollag, Elizabeth M Swisher
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer. JCO precision oncology 7 (2023)
Eduardo Gonzalez-Ochoa, Amit M Oza
An attempt to stretch the benefit: Re-challenge with PARP inhibitors in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stéphanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, Eduardo Gonzalez-Ochoa, Jeffrey P Bruce, Derek Wong, Arnavaz Danesh, Dax Torti, Jonathan Torchia, Alexander Fortuna, Sharanjit Singh, Matthew Irving, Kayla Marsh, Bernard Lam, Vanessa Speers, Aleksandra Yosifova, Ana Oaknin, Ainhoa Madariaga, Neesha C Dhani, Valerie Bowering, Amit M Oza, Trevor J Pugh
Identifying mechanisms of resistance by circulating tumour DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at time of PARP Inhibitor Progression. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anglin Dent, Kevin Faust, K H Brian Lam, Narges Alhangari, Alberto J Leon, Queenie Tsang, Zaid Saeed Kamil, Andrew F Gao, Prodipto Pal, Stéphanie Lheureux, Amit M Oza, Phedias Diamandis
HAVOC: Small-scale histomic mapping of cancer biodiversity across large tissue distances using deep neural networks. Science advances 9 (39) (2023)
Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J Rimel, Jørn Herrstedt, Amit M Oza, Ulrich Canzler, Jonathan S Berek, Antonio Gonzáles Martin, Phillipe Follana, Rosemary Lord, Masoud Azodi, Kasey Estenson, Zebin Wang, Yong Li, Divya Gupta, Ursula A Matulonis, Bin Feng
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer research communications 2 (11) (2022)
Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J Rimel, Jørn Herrstedt, Amit M Oza, Ulrich Canzler, Jonathan S Berek, Antonio Gonzáles Martin, Phillipe Follana, Rosemary Lord, Masoud Azodi, Kasey Estenson, Zebin Wang, Yong Li, Divya Gupta, Ursula A Matulonis, Bin Feng
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer research communications 2 (11) (2022)
Ana Carolina Veneziani, Amit M Oza
Taking the Road Less Traveled: Following Molecular Trail Markers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
Paul A DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael L Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit M Oza, Antonio Gonzáles Martin, Carol Aghajanian, William H Bradley, Cara A Mathews, Joyce F Liu, John McNamara, Elizabeth S Lowe, Mei-Lin Ah-See, Kathleen M Moore, null null
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Brooke M Grant, Trevor J Pugh, Amit M Oza
Molecular monitoring in endometrial cancer - ready for prime time? Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Shih Yu Cindy Yang, Trevor J Pugh, Amit M Oza
Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Ainhoa Madariaga, Amit M Oza
Wee1 Inhibition in Recurrent Serous Uterine Cancer: Science Paving the Way in a Challenging Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Susana Banerjee, Jesús García-Donas, Elizabeth M Swisher, David Cella, Juliette Meunier, Sandra Goble, Terri Cameron, Lara Maloney, Ann-Christin Mörk, Josh Bedel, Jonathan A Ledermann, Robert L Coleman
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (30) (2020)
Amit M Oza
Advances in prediction for ovarian cancer treatment stratification. Nature reviews. Clinical oncology 16 (2) (2019)

Amit M Oza.css-eqlu8i{font-size:small;padding-left:4px;} (Amit Oza)

Publication Activity (10 Years)

Top Topics

Top Venues

Amit M Oza (Amit Oza)